Breast reconstruction technology company AirXpanders says it's planning to enter the Australian market with an initial public offering worth as much as $36 million Australian.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1FdL1Vk
Cap comentari:
Publica un comentari a l'entrada